236 related articles for article (PubMed ID: 30190688)
1. C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review.
Fond G; Lançon C; Auquier P; Boyer L
Front Psychiatry; 2018; 9():392. PubMed ID: 30190688
[No Abstract] [Full Text] [Related]
2. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
[TBL] [Abstract][Full Text] [Related]
3. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
[TBL] [Abstract][Full Text] [Related]
4. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
[TBL] [Abstract][Full Text] [Related]
5. Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis.
Wang Z; Li P; Chi D; Wu T; Mei Z; Cui G
Oncotarget; 2017 Sep; 8(43):75445-75454. PubMed ID: 29088880
[TBL] [Abstract][Full Text] [Related]
6. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G;
Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795
[TBL] [Abstract][Full Text] [Related]
7. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
[TBL] [Abstract][Full Text] [Related]
8. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
Fond G; Berna F; Andrianarisoa M; Godin O; Leboyer M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Richieri R; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Schürhoff F;
Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):465-472. PubMed ID: 28238173
[TBL] [Abstract][Full Text] [Related]
9. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
[TBL] [Abstract][Full Text] [Related]
10. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.
Fond G; Boyer L; Schürhoff F; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Leboyer M;
Schizophr Res; 2018 Nov; 201():373-380. PubMed ID: 29843964
[TBL] [Abstract][Full Text] [Related]
11. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
Fond G; Godin O; Schürhoff F; Berna F; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
Psychiatry Res; 2018 Dec; 270():104-110. PubMed ID: 30245372
[TBL] [Abstract][Full Text] [Related]
12. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
Fond G; Godin O; Boyer L; Berna F; Andrianarisoa M; Coulon N; Brunel L; Bulzacka E; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Schürhoff F; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):985-992. PubMed ID: 29808267
[TBL] [Abstract][Full Text] [Related]
13. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M;
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539
[TBL] [Abstract][Full Text] [Related]
14. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.
Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV
Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579
[TBL] [Abstract][Full Text] [Related]
15. Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set.
Fond G; Bulzacka E; Boyer L; Llorca PM; Godin O; Brunel L; Andrianarisoa MG; Aouizerate B; Berna F; Capdevielle D; Chereau I; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Roger M; Passerieux C; Schandrin A; Urbach M; Vidalhet P; Schürhoff F; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2017 Sep; 267(6):587-594. PubMed ID: 27349652
[TBL] [Abstract][Full Text] [Related]
16. Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.
Fond G; Faugere M; Faget-Agius C; Cermolacce M; Richieri R; Boyer L; Lançon C
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):879-886. PubMed ID: 30078128
[TBL] [Abstract][Full Text] [Related]
17. The Role of Inflammation in the Treatment of Schizophrenia.
Fond G; Lançon C; Korchia T; Auquier P; Boyer L
Front Psychiatry; 2020; 11():160. PubMed ID: 32256401
[No Abstract] [Full Text] [Related]
18. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences.
Lee EE; Ancoli-Israel S; Eyler LT; Tu XM; Palmer BW; Irwin MR; Jeste DV
Am J Geriatr Psychiatry; 2019 Jan; 27(1):21-31. PubMed ID: 30442531
[TBL] [Abstract][Full Text] [Related]
19. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.
Fond G; Boyer L; Andrianarisoa M; Godin O; Bulzacka E; Berna F; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Leignier S; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schurhoff F; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():62-68. PubMed ID: 29678770
[TBL] [Abstract][Full Text] [Related]
20. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA
Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
